GlassScriptPhysician profile
Naba Goswami
NPI 1053471672
$2,454.43
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $421 · 2021: $261 · 2022: $392 · 2023: $504 · 2024: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $365.71 | 2019-2023 | Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $332.95 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $304.04 | 2022-2023 | |
| Pfizer INC. | $277.34 | 2019-2020 | |
| Novo Nordisk INC | $163.36 | 2019-2023 | Wegovy, Ozempic |
| Dexcom, INC. | $154.03 | 2024 | Dexcom G7 Gss (161) |
| Abbott Laboratories | $128.36 | 2021-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Amarin Pharma, INC. | $103.39 | 2019 | |
| Flowonix Medical Incorporated | $98.27 | 2020 | |
| Abbvie INC. | $92.91 | 2022-2023 | |
| Edwards Lifesciences Corporation | $69.49 | 2021 | |
| Daiichi Sankyo INC. | $65.63 | 2020-2021 | |
| Lilly USA, LLC | $65.36 | 2021-2023 | Mounjaro, Trulicity |
| Amgen INC. | $54.22 | 2021 | |
| Zealand Pharma US, INC. | $53.39 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $50.10 | 2019 | |
| Esperion Therapeutics, INC. | $28.76 | 2021 | |
| Merck Sharp & Dohme LLC | $18.30 | 2023 | Verquvo, Belsomra |
| Alnylam Pharmaceuticals INC. | $17.74 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naba Goswami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.